At InMed Technologies, we believe in 3 core principles:
- Claims made are based on our expertise of the subject matter, not an indirect third party;
- To truly understand cause and effect, you must conduct the research;
- We believe the relationship between the patient and the practitioner is paramount to good health.
These core principles set us apart from all other U.S. companies.
At InMed Technologies we offer specialized products based on our research, hence our specialty in encompassed bacteria and unique delivery systems (see About InMed for more details). We are partly owned by an Australian certified, biologic research and development company, Medlab, who are pioneering several new and novel pharmaceutical therapeutic products (www.medlab.co), giving InMed Technologies access to world-class research and development.
Further, at InMed Technologies we recognize the need to foster strong relationships between the patient and practitioner. To this end, our website strongly encourages a prospective patient to align with a practitioner and purchase through that practitioner’s virtual dispensary, allowing the practitioner to monitor dosage.
While InMed Technologies is a new company, we are not strangers to the U.S. pharmaceutical and nutraceutical marketplace. Previously we have advised, formulated and manufactured for other leading brands. Our decision to move to a “frontline” position was simple; we believe we can serve the needs of healthcare professionals and patients better than anyone else in the business.